Effect of chronic treatment with the calcium antagonist diltiazem in Duchenne muscular dystrophy
- 1 April 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 38 (4) , 609
- https://doi.org/10.1212/wnl.38.4.609
Abstract
We conducted a double-blind trial with the calcium antagonist, diltiazem (8 mg/kg/d), for 24 to 32 months in 22 boys with Duchenne muscular dystrophy, who were paired by functional activity and age. No adverse clinical or ECG effects of diltiazem were detected. In eight matched pairs, completing 28 months, manual muscle testing scores fell somewhat less in the diltiazem group (from 5.5 to 4.6) than in the placebo group (from 5.3 to 4.2), although the difference between groups was not significant (p = 0.06). The 95% confidence interval for the difference in slopes of regression lines obtained from trimonthly manual muscle tests on all subjects was markedly asymmetric in favor of the diltiazem group, but this difference was also not significant. There was less deterioration of functional activity of lower extremities in the diltiazem-treated group, when beginning and end values were analyzed (p = 0.03). However, the difference in slopes of regression lines obtained from trimonthly determinations was nonsignificant. Similarly, the beginning versus end comparisons of systolic and diastolic blood pressure showed a significantly (p < 0.05) smaller elevation of blood pressure in the diltiazem-treated group, but no difference was observed when the slopes of all values were analyzed. All other clinical and laboratory variables were unaffected by diltiazem treatment. The findings in manual muscle tests and functional activity suggest a beneficial trend with chronic diltiazem treatment in DMD.This publication has 9 references indexed in Scilit:
- A trial of flunarizine in the treatment of duchenne muscular dystrophyMuscle & Nerve, 1986
- Chronic allopurinol and adenine therapy in Duchenne muscular dystrophyNeurology, 1985
- Calcium and magnesium content in fetuses at risk and prenecrotic Duchenne muscular dystrophyNeurology, 1984
- Muscle calcium and magnesium content in Duchenne muscular dystrophyNeurology, 1982
- The effects of diltiazem in dystrophic hamstersMuscle & Nerve, 1982
- Parathyroid Ablation in Dystrophic HamstersJournal of Clinical Investigation, 1981
- Element analysis of skeletal muscle in duchenne muscular dystrophy using x‐ray fluorescence spectrometryMuscle & Nerve, 1980
- Intracellular calcium accumulation in Duchenne dystrophy and other myopathiesNeurology, 1978
- ULTRASTRUCTURAL LOCALIZATION OF CALCIUM IN NORMAL AND ABNORMAL SKELETAL-MUSCLE1977